References
- Kabakov AE, Kudryavtsev VA, Gabai VL. Hsp90 inhibitors as promising agents for radiotherapy. J Mol Med 2010;88:241–247.
- Bradbury CM, Markovina S, Wei SJ, Rene LM, Zoberi I, Horikoshi N, Gius D. Increased activator protein 1 activity as well as resistance to heat-induced radiosensitization, hydrogen peroxide, and cisplatin are inhibited by indomethacin in oxidative stress-resistant cells. Cancer Res 2001;61:3486–3492.
- Camphausen K, Tofilon PJ. Combining radiation and molecular targeting in cancer therapy. Cancer Biol Ther 2004;3:247–250.
- Moeller BJ, Dreher MR, Rabbani ZN, Schroeder T, Cao Y, Li CY, Dewhirst MW. Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Cancer Cell 2005;8:99–110.
- Wang J, Yi J. Cancer cell killing via ROS: to increase or decrease, that is the question. Cancer Biol Ther 2008;7:1875–1884.
- Pinthus JH, Bryskin I, Trachtenberg J, Lu JP, Singh G, Fridman E, Wilson BC. Androgen induces adaptation to oxidative stress in prostate cancer: implications for treatment with radiation therapy. Neoplasia 2007;9:68–80.
- Liu J. Pharmacology of oleanolic and ursolic acid. J Ethnophamacol 1995;49:57–68.
- Hsu YL, Kuo PL, Lin CC. Proliferative inhibition, cell-cycle dysregulation, and induction of apoptosis by ursolic acid in human non-small cell lung cancer A549 cells. Life Sci 2004;75:2303–2316.
- Hsu HY, Yang JJ, Lin CC. Effects of oleanolic acid and ursolic acid on inhibiting tumor growth and enhancing the recovery of hematopoietic system postirradiation in mice. Cancer Lett 1997;111:7–13.
- Williams JM, Lea N, Nord JM, Roberts LM, Milford DV, Taylor CM. Comparison of ribosome-inactivating proteins in the induction of apoptosis. Toxicol Lett 1997;91:121–127.
- Tauskela JS, Hewitt K, Kang LP, Comas T, Gendron T, Hakim A, . Evaluation of glutathione-sensitive fluorescent dyes in conical culture. Glia 2001;30:329–341.
- Tak JK, Park J-W. The use of ebselen for radioprotection in cultured cells and mice. Free Radic Biol Med 2009;46:1177–1185.
- Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302–310.
- Sundaresan M, Yu ZX, Ferrans CJ, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995;270:296–299.
- Mikkelsen RB, Wardman P. Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene 2003;22:5734–5754.
- Fulda S, Debatin KM. Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res 2004;64:337–346.
- Aggarwal BB, Shishodia S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 2006;71:1397–1421.
- Oh CJ, Kil IS, Park, CI, Yang CH, Park J-W. Ursolic acid regulates high glucose-induced apoptosis. Free Rad Res 2007;41:638–644.
- Tu HY, Huang AM, Wei BL, Gan KH, Hour TC, Yang SC, . Ursolic acid derivatives induce cell cycle arrest and apoptosis in NTUB1 cells associated with reactive oxygen species. Bioorg Med Chem 2009;17:7265–7274.
- Creagh EM, Martin SJ. Caspases: cellular demolition experts. Biochem Soc Trans 2001;29:696–702.
- Li H, Zhu H, Xu CJ, Yuan J. Cleavage of Bid by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998;94:491–501.
- Pastorino JG, Simbula G, Yamamoto K, Glascott PA, Rothman RJ, Farber JL. The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J Biol Chem 1996;271:29792–29798.
- Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309–1312.
- Prasad S, Yadav VR, Kannappan R, Aggarwal BB. Ursolic acid, a pentacyclin triterpene, potentiates TRAIL-induced apoptosis through p53-independent up-regulation of death receptors. Free Rad Res 2011;286:5546–5557.
- Shanmugam MK, Rajendran P, Li F, Nema T, Vali S, Abbasi T, . Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice. J Mol Med 2011;89;713–727.